|
Diabetes, Vol 48, Issue 2 292-298, Copyright © 1999 by American Diabetes Association
Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting
K Ekberg, BR Landau, A Wajngot, V Chandramouli, S Efendic, H Brunengraber and J Wahren
Department of Clinical Physiology, Karolinska Hospital, Stockholm, Sweden. kekberg@klinfys.ks.se
Contributions of renal glucose production to whole-body glucose turnover
were determined in healthy individuals by using the arteriovenous balance
technique across the kidneys and the splanchnic area combined with
intravenous infusion of [U-13C6]glucose, [3-(3)H]glucose, or
[6-(3)H]glucose. In the postabsorptive state, the rate of glucose
appearance was 11.5 +/- 0.6 micromol x kg(-1) x min(-1). Hepatic glucose
production, calculated as the sum of net glucose output (9.8 +/- 0.8
micromol x kg(-1) x min(-1)) and splanchnic glucose uptake (2.2 +/- 0.3
micromol x kg(-1) x min(-1)) accounted for the entire rate of glucose
appearance. There was no net exchange of glucose across the kidney and no
significant renal extraction of labeled glucose. The renal contribution to
total glucose production calculated from the arterial, hepatic, and renal
venous 13C-enrichments (glucose M+6) was 5 +/- 2%. In the 60-h fasted
state, the rate of glucose appearance was 8.2 +/- 0.3 micromol x kg(-1) x
min(-1). Hepatic glucose production, estimated as net splanchnic output
(5.8 +/- 0.7 micromol x kg(-1) x min(-1)) plus splanchnic uptake (0.6 +/-
0.3 micromol x kg(-1) x min(-1)) accounted for 79% of the rate of glucose
appearance. There was a significant net renal output of glucose (0.9 +/-
0.3 micromol x kg(-1) x min(-1)), but no significant extraction of labeled
glucose across the kidney. The renal contribution to whole-body glucose
turnover calculated from the 13C-enrichments was 24 +/- 3%. We concluded
that 1) glucose production by the human kidney in the postabsorptive state,
in contrast to recent reports, makes at most only a minor contribution
(approximately 5%) to blood glucose homeostasis, but that 2) after 60-h of
fasting, renal glucose production may account for 20-25% of whole-body
glucose turnover.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Desvergne, L. Michalik, and W. Wahli
Transcriptional Regulation of Metabolism
Physiol Rev,
April 1, 2006;
86(2):
465 - 514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Brackenridge, E. R. Pearson, F. Shojaee-Moradie, A. T. Hattersley, D. Russell-Jones, and A. M. Umpleby
Contrasting Insulin Sensitivity of Endogenous Glucose Production Rate in Subjects With Hepatocyte Nuclear Factor-1{beta} and -1{alpha} Mutations
Diabetes,
February 1, 2006;
55(2):
405 - 411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Eid, S. Bodin, B. Ferrier, H. Delage, M. Boghossian, M. Martin, G. Baverel, and A. Conjard
Intrinsic Gluconeogenesis Is Enhanced in Renal Proximal Tubules of Zucker Diabetic Fatty Rats
J. Am. Soc. Nephrol.,
February 1, 2006;
17(2):
398 - 405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fujimoto, N. Shimizu, K. Kunii, J.A. J. Martyn, K. Ueki, and M. Kaneki
A Role for iNOS in Fasting Hyperglycemia and Impaired Insulin Signaling in the Liver of Obese Diabetic Mice
Diabetes,
May 1, 2005;
54(5):
1340 - 1348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Jin, S. C. Burgess, M. E. Merritt, A. D. Sherry, and C. R. Malloy
Differing mechanisms of hepatic glucose overproduction in triiodothyronine-treated rats vs. Zucker diabetic fatty rats by NMR analysis of plasma glucose
Am J Physiol Endocrinol Metab,
April 1, 2005;
288(4):
E654 - E662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mithieux, F. Rajas, and A. Gautier-Stein
A Novel Role for Glucose 6-Phosphatase in the Small Intestine in the Control of Glucose Homeostasis
J. Biol. Chem.,
October 22, 2004;
279(43):
44231 - 44234.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Battezzati, A. Caumo, F. Martino, L. P. Sereni, J. Coppa, R. Romito, M. Ammatuna, E. Regalia, D. E. Matthews, V. Mazzaferro, et al.
Nonhepatic glucose production in humans
Am J Physiol Endocrinol Metab,
January 1, 2004;
286(1):
E129 - E135.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Meyer, M. Stumvoll, S. Welle, H. J. Woerle, M. Haymond, and J. Gerich
Relative importance of liver, kidney, and substrates in epinephrine-induced increased gluconeogenesis in humans
Am J Physiol Endocrinol Metab,
October 1, 2003;
285(4):
E819 - E826.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kashyap, R. Belfort, A. Gastaldelli, T. Pratipanawatr, R. Berria, W. Pratipanawatr, M. Bajaj, L. Mandarino, R. DeFronzo, and K. Cusi
A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes
Diabetes,
October 1, 2003;
52(10):
2461 - 2474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Magnuson, P. She, and M. Shiota
Gene-altered Mice and Metabolic Flux Control
J. Biol. Chem.,
August 29, 2003;
278(35):
32485 - 32488.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Jin, K. Uyeda, T. Kawaguchi, S. C. Burgess, C. R. Malloy, and A. D. Sherry
Increased Hepatic Fructose 2,6-Bisphosphate after an Oral Glucose Load Does Not Affect Gluconeogenesis
J. Biol. Chem.,
August 1, 2003;
278(31):
28427 - 28433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Basu, B. Di Camillo, G. Toffolo, A. Basu, P. Shah, A. Vella, R. Rizza, and C. Cobelli
Use of a novel triple-tracer approach to assess postprandial glucose metabolism
Am J Physiol Endocrinol Metab,
January 1, 2003;
284(1):
E55 - E69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Miyazaki, L. Glass, C. Triplitt, E. Wajcberg, L. J. Mandarino, and R. A. DeFronzo
Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus
Am J Physiol Endocrinol Metab,
December 1, 2002;
283(6):
E1135 - E1143.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gastaldelli, Y. Miyazaki, M. Pettiti, M. Matsuda, S. Mahankali, E. Santini, R. A. DeFronzo, and E. Ferrannini
Metabolic Effects of Visceral Fat Accumulation in Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
November 1, 2002;
87(11):
5098 - 5103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Miyazaki, A. Mahankali, M. Matsuda, S. Mahankali, J. Hardies, K. Cusi, L. J. Mandarino, and R. A. DeFronzo
Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients
J. Clin. Endocrinol. Metab.,
June 1, 2002;
87(6):
2784 - 2791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Meyer, J. M. Dostou, S. L. Welle, and J. E. Gerich
Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis
Am J Physiol Endocrinol Metab,
February 1, 2002;
282(2):
E419 - E427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Landau
Methods for measuring glycogen cycling
Am J Physiol Endocrinol Metab,
September 1, 2001;
281(3):
E413 - E419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cersosimo, P. Garlick, and J. Ferretti
Abnormal Glucose Handling by the Kidney in Response to Hypoglycemia in Type 1 Diabetes
Diabetes,
September 1, 2001;
50(9):
2087 - 2093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fosgerau, S. D. Mittelman, A. Sunehag, M. K. Dea, K. Lundgren, and R. N. Bergman
Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model
Am J Physiol Endocrinol Metab,
August 1, 2001;
281(2):
E375 - E383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Basu, R. Basu, P. Shah, A. Vella, C. M. Johnson, M. Jensen, K. S. Nair, W. F. Schwenk, and R. A. Rizza
Type 2 Diabetes Impairs Splanchnic Uptake of Glucose but Does Not Alter Intestinal Glucose Absorption During Enteral Glucose Feeding: Additional Evidence for a Defect in Hepatic Glucokinase Activity
Diabetes,
June 1, 2001;
50(6):
1351 - 1362.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. N. Båvenholm, J. Pigon, C.-G. Östenson, and S. Efendic
Insulin Sensitivity of Suppression of Endogenous Glucose Production Is the Single Most Important Determinant of Glucose Tolerance
Diabetes,
June 1, 2001;
50(6):
1449 - 1454.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Croset, F. Rajas, C. Zitoun, J.-M. Hurot, S. Montano, and G. Mithieux
Rat Small Intestine Is an Insulin-Sensitive Gluconeogenic Organ
Diabetes,
April 1, 2001;
50(4):
740 - 746.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. Moller, R. A. Rizza, G. C. Ford, and K. S. Nair
Assessment of Postabsorptive Renal Glucose Metabolism in Humans With Multiple Glucose Tracers
Diabetes,
April 1, 2001;
50(4):
747 - 751.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. E. Gerich
Measurements of Renal Glucose Release
Diabetes,
April 1, 2001;
50(4):
905 - 905.
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Cusi, S. Cukier, R. A. DeFronzo, M. Torres, F. M. Puchulu, and J. C. P. Redondo
Vanadyl Sulfate Improves Hepatic and Muscle Insulin Sensitivity in Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
March 1, 2001;
86(3):
1410 - 1417.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. E. Gerich, C. Meyer, H. J. Woerle, and M. Stumvoll
Renal Gluconeogenesis: Its importance in human glucose homeostasis
Diabetes Care,
February 1, 2001;
24(2):
382 - 391.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. G. Bischof, M. Krssak, M. Krebs, E. Bernroider, H. Stingl, W. Waldhäusl, and M. Roden
Effects of Short-Term Improvement of Insulin Treatment and Glycemia on Hepatic Glycogen Metabolism in Type 1 Diabetes
Diabetes,
February 1, 2001;
50(2):
392 - 398.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. She, M. Shiota, K. D. Shelton, R. Chalkley, C. Postic, and M. A. Magnuson
Phosphoenolpyruvate Carboxykinase Is Necessary for the Integration of Hepatic Energy Metabolism
Mol. Cell. Biol.,
September 1, 2000;
20(17):
6508 - 6517.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. S. Streeper, C. A. Svitek, J. K. Goldman, and R. M. O'Brien
Differential Role of Hepatocyte Nuclear Factor-1 in the Regulation of Glucose-6-phosphatase Catalytic Subunit Gene Transcription by cAMP in Liver- and Kidney-derived Cell Lines
J. Biol. Chem.,
April 14, 2000;
275(16):
12108 - 12118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Gerich, C. Meyer, and M. W. Stumvoll
Hormonal Control of Renal and Systemic Glutamine Metabolism
J. Nutr.,
April 1, 2000;
130(4):
995 - 995.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. R. Landau
Limitations in the use of [U-13C6]glucose to estimate gluconeogenesis
Am J Physiol Endocrinol Metab,
September 1, 1999;
277(3):
E408 - E413.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Meyer, M. Stumvoll, J. Dostou, S. Welle, M. Haymond, and J. Gerich
Renal substrate exchange and gluconeogenesis in normal postabsorptive humans
Am J Physiol Endocrinol Metab,
February 1, 2002;
282(2):
E428 - E434.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|